Losses for Biomet Inc., a bellwether for the U.S. orthopedic market, soared during the fourth quarter and fiscal 2011, largely due to a nearly $1 billion writedown related to its re-assessment of the European market.
Biomet
Blackstone Group in the hunt for Kinetic Concepts
One of the potential bidders for Kinetic Concepts Inc. (NYSE:KCI) is the Blackstone Group, a private equity firm with a massive $16 billion buyout fund and a past history of making big bets in med-tech.
FDA probes for data on metal-on-metal hip implants
The FDA asked Johnson & Johnson (NYSE:JNJ) and a score of other medical device makers for data on metal levels in the blood of patients implanted with metal-on-metal hip implants.
FDA clears Biomet’s hip implant | Regulatory roundup
Biomet Inc. received FDA 510(k) clearance for its new hip replacement device.
Warsaw, Ind.-based company said its Active Articulation E1 dual mobility hip system is an implant option for orthopedic surgeons performing hip replacement surgery.
Orthopedic survey: Stryker, Zimmer the most innovative companies in hips and knees
Biomet sees slight sales increase as losses widen | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Covidien wins 510(k) clearance for small jaw surgical tool | Regulatory roundup
Covidien plc (NYSE:COV) won 510(k) clearance for a new "small jaw" cutting and sealing surgical instrument.
The clearance adds another device to the Mansfield, Mass.-based medical products maker’s 12-year-old LigaSure line of surgical tools.
Neovasc wins European approval for bovine tissue-based surgical patch | Regulatory roundup
Here’s a roundup of companies announcing clearances and approvals from the Food & Drug Administration and foreign regulatory agencies. Check out MassDevice’s compilation of the latest regulatory news for additional clearances and approvals.
FDA ups the ante for jaw implants
The Food & Drug Administration is ordering all three U.S. manufacturers of a type of jaw implant to run post-market surveillance on the devices to track the rate of removal or replacement.
The zombie deal that won’t die: Smith & Nephew
No matter how many times Smith & Nephew (NYSE:SNN) says it’s not talking merger, somebody else says it is.